(March 18th-19th, 2021 – Online Conference)
Hundreds of biopharma executives congregated for ACCESS CHINA to meet with the potential partners for development, licensing or commercial collaborations. The two-day conference agenda included company presentations and panel discussion.
This conference is the first “CHINA Innovation” themed corporate access event. We selected 21 Chinese innovative pharma companies looking for global or regional out-licensing opportunities.
“China Biotech Innovation 50 Report” Release
Panel session: Preparing You and Your Firm for a Global Licensing Campaign
Presentation of 21 Chinese Biopharmas with 50 Innovative Assets
Thank you for joining us at ACCESS CHINA Spring Forum 2021 and we hope to see you at our next coming event in June.
Sincerely
ACCESS CHINA Forum Organizing Committee